Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
Archives of Internal Medicine
|
November 1, 1983
Yersinia enterocolitica endocarditis
J S Appelbaum, G Wilding, L J Morse
Science (New York, N.Y.)
|
March 11, 1977
Reduced warfarin binding of albumin variants
G Wilding, E S Blumberg, E S Vesell
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 1998
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
H Miyamoto, S Yeh, G Wilding, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice
D Church, Y Zhang, R Rago, et al.
The Prostate
|
January 1, 1990
Phosphoinositide metabolism in human prostate cancer cells in vitro
G Wilding, E P Gelmann, C E Freter
In Vitro Cellular & Developmental Biology. Animal
|
October 1, 1995
Use of a DNA microfluorometric assay to measure proliferative response of mink lung cells to purified TGF beta and to TGF beta activity found in prostate cell conditioned medium
J Mitchen, D Bletzinger, R Rago, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 1, 1991
v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells
H J Voeller, G Wilding, E P Gelmann
Cancer Research
|
December 15, 1992
Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells
R P Rago, P C Brazy, G Wilding
Biochemical and Biophysical Research Communications
|
September 15, 1993
Identification of an androgen-induced C3-P4 DNA binding protein in the cytosol of rat ventral prostate
Y L Zhang, C Wang, G Wilding, et al.
Urology
|
June 1, 1995
Penile Merkel cell carcinoma
S Tomic, T F Warner, E Messing, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
Archives of Internal Medicine
|
November 1, 1983
Yersinia enterocolitica endocarditis
J S Appelbaum, G Wilding, L J Morse
Science (New York, N.Y.)
|
March 11, 1977
Reduced warfarin binding of albumin variants
G Wilding, E S Blumberg, E S Vesell
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 1998
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
H Miyamoto, S Yeh, G Wilding, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice
D Church, Y Zhang, R Rago, et al.
The Prostate
|
January 1, 1990
Phosphoinositide metabolism in human prostate cancer cells in vitro
G Wilding, E P Gelmann, C E Freter
In Vitro Cellular & Developmental Biology. Animal
|
October 1, 1995
Use of a DNA microfluorometric assay to measure proliferative response of mink lung cells to purified TGF beta and to TGF beta activity found in prostate cell conditioned medium
J Mitchen, D Bletzinger, R Rago, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 1, 1991
v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells
H J Voeller, G Wilding, E P Gelmann
Cancer Research
|
December 15, 1992
Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells
R P Rago, P C Brazy, G Wilding
Biochemical and Biophysical Research Communications
|
September 15, 1993
Identification of an androgen-induced C3-P4 DNA binding protein in the cytosol of rat ventral prostate
Y L Zhang, C Wang, G Wilding, et al.
Urology
|
June 1, 1995
Penile Merkel cell carcinoma
S Tomic, T F Warner, E Messing, et al.
Page
of 11